Synaptogyrin-2 (encoded by SYNGR2) is an integral membrane protein of synaptic vesicles, with aliases including SGYR2 and synaptogyrin II. It regulates synaptic vesicle trafficking and exocytosis by interacting with SNARE complex components (e.g., syntaxin-1), facilitating neurotransmitter release at presynaptic terminals.
Dysregulation of SYNGR2 is linked to neuropsychiatric disorders like schizophrenia (via genome-wide association studies) and autism spectrum disorders, likely due to impaired synaptic function. While no drugs directly targeting SYNGR2 are approved, it is a potential candidate in research on modulating synaptic vesicle dynamics for neurological condition treatments.
Recombinant Human Synaptogyrin-2 (SYNGR2), partial (CSB-MP023012HU1)
Validated Data
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
The purity of SYNGR2 was greater than 95% as determined by SEC-HPLC
The following SYNGR2 reagents supplied by CUSABIO are manufactured under a strict quality control system. Multiple applications have been validated and solid technical support is offered.
SYNGR2 Proteins for Homo sapiens (Human)
| Code | Product Name | Source |
|---|---|---|
| CSB-CF023012HU | Recombinant Human Synaptogyrin-2 (SYNGR2) | in vitro E.coli expression system |
| CSB-EP023012HU1 CSB-BP023012HU1 CSB-EP023012HU1-B |
Recombinant Human Synaptogyrin-2 (SYNGR2), partial | E.coli Baculovirus In Vivo Biotinylation in E.coli |
| CSB-MP023012HU1 | Recombinant Human Synaptogyrin-2 (SYNGR2), partial | Mammalian cell |
| CSB-YP023012HU1 | Recombinant Human Synaptogyrin-2 (SYNGR2), partial | Yeast |